EBV-RELATED LYMPHOPROLIFERATIVE DISORDER

Clinical trials for EBV-RELATED LYMPHOPROLIFERATIVE DISORDER explained in plain language.

Never miss a new study

Get alerted when new EBV-RELATED LYMPHOPROLIFERATIVE DISORDER trials appear

Sign up with your email to follow new studies for EBV-RELATED LYMPHOPROLIFERATIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Supercharged immune cells target Virus-Driven cancers in new trial

Disease control Recruiting now

This early-stage study tests a new type of cell therapy for lymphoma linked to Epstein-Barr virus (EBV). Researchers take a patient's own immune cells, modify them with a gene called C7R to help them survive longer, and infuse them back to attack the cancer. The main goals are to…

Matched conditions: EBV-RELATED LYMPHOPROLIFERATIVE DISORDER

Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

EBV-RELATED LYMPHOPROLIFERATIVE DISORDER

Get alerted when new EBV-RELATED LYMPHOPROLIFERATIVE DISORDER trials appear

Supercharged immune cells target Virus-Driven cancers in new trial